Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune inflammatory disease that targets synovial joints and commonly involves the temporomandibular joint (TMJ).[1][2] The hallmark pathologic process is synovial hyperplasia with formation of an invasive pannus that erodes cartilage and bone through osteoclast-mediated resorption and matrix metalloproteinase activity.[1][3] In the maxillofacial region, RA produces progressive degenerative and erosive changes of the mandibular condyle and temporal component, with characteristic radiographic findings of condylar flattening, erosion, and joint space narrowing.[4][5] The disease is managed primarily through systemic disease-modifying antirheumatic drug (DMARD) therapy, with surgical intervention reserved for refractory cases.[6][7]

The current accepted term is rheumatoid arthritis, classified under the 2010 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) criteria.[8] When the TMJ is the focus, the condition is referred to as rheumatoid arthritis of the temporomandibular joint. In children, the related entity is juvenile idiopathic arthritis (JIA), formerly termed juvenile rheumatoid arthritis or juvenile chronic arthritis.[6][9] The abbreviation RA is universally accepted. The term "rheumatoid TMJ arthritis" appears in the imaging literature but is not a formal classification entity.

• RA affects approximately 1% of the global population, with a female-to-male ratio of roughly 3:1.[2][10]
• Peak onset occurs between the fourth and sixth decades; JIA presents before age 16.[2][6]
• TMJ involvement can be demonstrated in 40–90% of RA patients on imaging, although it is frequently asymptomatic. Clinically symptomatic TMJ disease is present in a smaller proportion, with signs and symptoms of temporomandibular disorders reported in 8–70% of RA patients across studies.[6][11]
• TMJ symptoms in adults typically develop late in the disease course, often after other joints are already affected.[9]
• Risk factors for TMJ involvement include female sex, anti-citrullinated protein antibody (ACPA) positivity, higher disease activity scores, and cervical spine involvement.[4][11]

Presentation and symptoms

• TMJ pain is typically a deep, dull, aching preauricular discomfort exacerbated by jaw function.[12][13]
• Limited mouth opening is common, with reduced maximal interincisal distance correlating with elevated inflammatory markers.[13][14]
• Restricted lateral, protrusive, and retrusive mandibular movements are characteristic.[14]
• Crepitation is the most frequent joint sound and correlates with structural damage to the disc and articular cartilage.[13][15]
• Orofacial pain is a predominant complaint, reported in the majority of RA patients with TMJ involvement.[13]

Examination findings

• Tenderness on palpation of the TMJ and masticatory muscles, particularly the medial pterygoid and anterior digastric.[13]
• Preauricular swelling may be present during acute inflammatory phases.[12]
• In JIA, condylar growth restriction can produce micrognathia, mandibular retrognathia, and progressive Class II malocclusion with anterior open bite.[9][12]

Complications and red flags

• Ankylosis of the TMJ may develop in severe or long-standing cases, particularly in JIA.[9][12]
• Cervical spine involvement occurs in up to 75–86% of RA patients and may produce atlantoaxial subluxation, a potentially life-threatening complication requiring screening before general anesthesia.[10][16][17]
• Secondary Sjögren syndrome occurs in approximately 10% of RA patients, contributing to xerostomia and increased caries risk.[18][19]
• Periodontal disease is significantly more prevalent in RA, with a bidirectional pathogenic relationship involving shared inflammatory mediators and the role of Porphyromonas gingivalis in protein citrullination.[20][21][22]

Oral manifestations related to RA treatment

• Methotrexate and other immunosuppressants may cause oral ulcerations and increased infection susceptibility.[23][24]
• Gingival overgrowth may occur with certain medications.[23]
• Rheumatoid nodules in the oral mucosa are extremely rare.[25]

Location and distribution

• The TMJ is the primary site of RA involvement in the maxillofacial region, typically affected bilaterally, though asymmetric involvement occurs.[11][15]
• The mandibular condyle is the most commonly affected osseous component; the articular eminence and glenoid fossa are involved less frequently.[4][26]
• Cervical spine changes, particularly at C1–C2, may be visible on lateral cephalometric or panoramic radiographs as incidental findings.[16][17]

Periphery and shape

• Condylar flattening is one of the most common findings, reflecting loss of the normal convex contour of the condylar head.[4][5][27]
• The condyle may assume an irregular, pointed, or pencil-shaped morphology in advanced disease.[15]
• Flattening of the articular fossa is also observed and correlates with disease activity.[4]

Internal architecture

• Erosion of the condylar cortex is characteristic, appearing as focal areas of cortical discontinuity with adjacent subcortical radiolucency.[5]
• Subchondral sclerosis may develop as a reparative response, producing increased density beneath the articular surface.[5][27]
• Subchondral cysts (geodes) appear as well-defined radiolucent foci within the condyle.[27]
• Osteophytes may form at the condylar margins, though they are more characteristic of degenerative osteoarthritis than inflammatory RA.[5]

Effects on teeth and adjacent structures

• Progressive condylar resorption leads to shortening of the ramus–condyle unit, which may produce posterior rotation of the mandible and anterior open bite.[9][12]
• Joint space narrowing results from cartilage destruction and is an indirect radiographic sign, since cartilage itself is radiotranslucent.[1][9]
• Reduced condylar height and anteroposterior dimensions are measurable findings that correlate with ACPA positivity and disease activity.[4]
• Generalized osteopenia of the mandible may be present as part of systemic bone loss driven by RANKL-mediated osteoclastogenesis.[3]
• Alveolar bone loss from concurrent periodontal disease is common and may be visible on panoramic and periapical radiographs.[20][21]

Growth pattern and extent

• In adults, changes are typically slowly progressive, with the overall grade of radiographic changes advancing over time; progression correlates with elevated CRP.[28]
• In JIA, condylar involvement during growth produces mandibular hypoplasia with facial asymmetry (unilateral) or retrognathia (bilateral).[9][12]
• Early disease may show no radiographic abnormality on conventional imaging; osseous changes become apparent as the disease progresses.[9][29]

Cortical involvement

• Cortical erosion of the condyle is the hallmark osseous finding, ranging from subtle surface irregularity to extensive destruction.[5][15]
• Erosion of the articular eminence and glenoid fossa occurs occasionally and indicates more advanced disease.[15][26]
• In severe cases, near-complete resorption of the condyle may occur.[9]

Recognized variants and staging

• Panoramic radiography serves as a screening tool and can detect condylar erosion, flattening, and restricted condylar translation.[14][15]
• CBCT provides superior three-dimensional assessment of osseous changes including erosion, flattening, sclerosis, osteophytes, and subchondral cysts, and demonstrates significantly higher prevalence of these changes in RA patients compared with controls.[5][27]
• Radiographic findings vary by disease stage: early disease may show only subtle cortical irregularity, while established disease demonstrates erosion, flattening, and joint space narrowing, and late-stage disease may show extensive condylar resorption or ankylosis.[9][29]

MRI

Contrast-enhanced MRI is the reference standard for diagnosing TMJ arthritis in RA, with superior ability to detect soft tissue changes not visible on radiographs or CBCT.[6][30] Characteristic findings include:

• Synovial proliferation (pannus), seen as enhancing tissue surrounding the condyle, present in the majority of RA patients with TMJ involvement.[26]
• Abnormal bone marrow signal in the mandibular condyle, reflecting inflammatory edema, is a characteristic finding that distinguishes RA from non-inflammatory conditions.[26]
• Disc abnormalities including anterior displacement and morphologic deformity are common.[15][26]
• Joint effusion is observed occasionally.[14][26]
• Reduced articular cartilage thickness is demonstrable.[15]
• Lymph node swelling in the parotid glands is a characteristic associated finding.[26]

Ultrasound

Ultrasound can detect joint effusion, synovial hypertrophy, and power Doppler signal indicating active inflammation, and may distinguish inflammatory from mechanical TMJ pathology.[31][32] Erosions detected on ultrasound are the finding most significantly correlated with clinical symptoms.[31]

PET/CT

FDG-PET/CT is the only imaging modality capable of quantifying active TMJ inflammation and may demonstrate increased metabolic activity before structural changes are apparent.[29][33] Its role remains primarily investigational for TMJ assessment.

The differential diagnosis of TMJ changes in RA centers on distinguishing inflammatory arthritis from degenerative disease and other arthropathies. Bilateral condylar erosion with systemic joint involvement and positive serology strongly favors RA, but imaging findings alone are often nonspecific.

The highest-risk diagnostic pitfall is misattributing RA-related TMJ erosion to primary osteoarthritis, particularly in older patients with concurrent degenerative changes. Serologic testing (RF, ACPA) and assessment of other joint involvement are essential to avoid this error.[7][39]

Synovial pathology

The histologic hallmark of RA is the rheumatoid pannus—a hyperplastic synovial tissue characterized by:

• Expansion of the synovial lining layer with fibroblast-like and macrophage-like synoviocytes.[1][2]
• Dense inflammatory infiltrate of CD4+ and CD8+ T cells, B cells, plasma cells, macrophages, and dendritic cells.[2]
• Prominent neovascularization (angiogenesis).[1][2]
• The pannus extends over cartilage surfaces and invades bone at the cartilage–bone junction.[1][3]

Bone and cartilage destruction

• Osteoclasts differentiate at the pannus–bone interface under the influence of RANKL, TNF, and IL-6, producing focal bone erosions.[1][3]
• Cartilage degradation is mediated by matrix metalloproteinases (collagenases, stromelysins, gelatinases) and ADAMTS5, produced by activated synovial fibroblasts and chondrocytes.[3]
• Wnt signaling pathway inhibitors prevent osteoblast-mediated bone repair, contributing to the irreversibility of erosions.[3]

Rheumatoid nodules

Subcutaneous rheumatoid nodules occur in approximately 30–40% of RA patients and consist of a central zone of fibrinoid necrosis surrounded by palisading histiocytes and a peripheral zone of chronic inflammatory cells.[2][18] Oral mucosal rheumatoid nodules are extremely rare; a reported case in the lower lip showed a necrobiotic nodule with palisaded histiocytes in the deep mucosa.[25]

Radiologic-pathologic correlation

The radiographic erosions correspond to sites of pannus invasion at the bare areas of bone where synovium attaches directly to periosteum without intervening cartilage. Joint space narrowing reflects cartilage loss that is histologically evident as chondrocyte death and matrix degradation.[1][3]

Systemic disease management

• Methotrexate monotherapy is the preferred first-line DMARD for moderate-to-high disease activity, following a treat-to-target strategy endorsed by ACR and EULAR.[7][40]
• Biologic DMARDs (TNF inhibitors, IL-6 inhibitors, and others) are indicated for inadequate response to conventional synthetic DMARDs.[7][40]
• Targeted synthetic DMARDs (JAK inhibitors) represent an additional therapeutic class.[7]
• NSAIDs and short-course glucocorticoids provide symptomatic relief but do not prevent structural damage.[7]

TMJ-specific management

• Conservative measures include physical therapy, jaw exercises, occlusal splints, and biobehavioral therapy.[6][9]
• Antirheumatic basal therapy (systemic DMARDs) is successful in controlling TMJ disease in the majority of patients.[6]
• Intra-articular corticosteroid injection should be limited to a single injection in refractory cases due to risk of condylar damage.[6][30]
• Arthroscopy and arthrocentesis provide temporary symptom relief and functional improvement when conservative treatment fails.[6]
• Open surgical intervention, including alloplastic TMJ replacement, is reserved for severe cases refractory to all other measures and is required in fewer than 1% of patients.[6][30]

Dental considerations

• Oral hygiene modifications may be necessary due to limited manual dexterity from hand joint involvement.[23][24]
• Xerostomia management is important in patients with secondary Sjögren syndrome.[18][24]
• Cervical spine screening is recommended before procedures requiring general anesthesia or significant neck extension due to risk of atlantoaxial subluxation.[10][16]
• Periodontal evaluation and management should be integrated into RA care given the bidirectional disease relationship.[20][21]

Prognosis

• Early diagnosis and aggressive DMARD therapy have substantially improved long-term outcomes, reducing the severity of articular and systemic bone loss.[3][7]
• Degenerative TMJ changes may progress despite antirheumatic therapy.[27]
• Oligosymptomatic and asymptomatic TMJ involvement is common even with radiologically evident joint damage, underscoring the importance of imaging surveillance.[6]
• Disease activity score (DAS28) and ACPA positivity are stronger predictors of TMJ structural damage than rheumatoid factor.[4]

Periodontal disease and RA pathogenesis

The bidirectional relationship between periodontitis and RA has significant implications for oral and maxillofacial practitioners. Porphyromonas gingivalis produces peptidylarginine deiminase, which citrullinates proteins and may trigger ACPA production, linking periodontal infection to RA initiation.[1][22] RA patients exhibit higher bacterial load, more diverse oral microbiota, and increased periodontal pathogens compared with controls.[20] Treatment of periodontitis may improve RA disease activity.[20][21]

Cervical spine instability

Atlantoaxial subluxation occurs in up to 58% of RA patients with cervical involvement and may be clinically silent.[17] Lateral cervical radiographs should be obtained before general anesthesia or procedures requiring neck manipulation. An anterior atlantodental interval exceeding 3 mm on flexion views is considered abnormal.[10][16]

Juvenile idiopathic arthritis

The ACR recommends treatment of TMJ arthritis in JIA regardless of clinical symptoms, with rapid escalation to biologic DMARDs given the destructive nature of the disease and its impact on mandibular growth.[40] Annual clinical screening of the TMJ is recommended throughout childhood and adolescence.[6]